2011
New tau species

Yann Verdier , Joelle Vinh , Giovanni Chiappetta , Malika Hamdane

1
2018
Neuronal tau species transfer to astrocytes and induce their loss according to tau aggregation state.

Karine Cambon , Emmanuel Brouillet , Gilles Bonvento , Marie-Claude Gaillard
Brain 144 ( 4) 1167 -1182

2021
Meningeal γδ T Cells Impact on Cognition in Health and Disease

Helena Brigas , Miguel Ribeiro , Joana Coelho , Paula Pousinha
Biological Psychiatry 89 ( 9)

2021
THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency.

Karine Cambon , Emmanuel Brouillet , Gilles Bonvento , Marie-Claude Gaillard
Neurobiology of Disease 155 105398 -105398

2021
Glial Purinergic Signaling in Neurodegeneration

Annett Halle , Annett Halle , David Blum , Kevin Carvalho
Frontiers in Neurology 12 654850

2021
Human platelet lysate biotherapy for traumatic brain injury: preclinical assessment.

Thierry Burnouf , Luc Buée , David Devos , David Blum
Brain

2021
69
2011
Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase

Jean-Baptiste Gibier , Brigitte Hémon , Mélanie Fanchon , Kelly Gaudelot
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863 ( 6) 1336 -1349

20
2017
Biochemistry of Tau in Alzheimer’s disease and related neurological disorders

Nicolas Sergeant , Alexis Bretteville , Malika Hamdane , Marie-Laure Caillet-Boudin
Expert Review of Proteomics 5 ( 2) 207 -224

197
2008
A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists.

David Blum , Marie-Christine Galas , Annita Pintor , Emmanuel Brouillet
The Journal of Neuroscience 23 ( 12) 5361 -5369

108
2003
Altered Neuronal Excitability in Cerebellar Granule Cells of Mice Lacking Calretinin

David Gall , Céline Roussel , Isabella Susa , Egidio D'Angelo
The Journal of Neuroscience 23 ( 28) 9320 -9327

118
2003
Alzheimer's disease risk, obesity and tau: is insulin resistance guilty?

David Blum , Luc Buée
Expert Review of Neurotherapeutics 13 ( 5) 461 -463

5
2013
Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.

Constance Delaby , Audrey Gabelle , David Blum , Susanna Schraen-Maschke
Frontiers in Neurology 6 181 -181

29
2015
Association between caffeine intake and age at onset in Huntington's disease.

Clémence Simonin , Cécile Duru , Julia Salleron , Pascale Hincker
Neurobiology of Disease 58 179 -182

45
2013
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.

Claire-Marie Dhaenens , Sylvie Burnouf , Clémence Simonin , Edwige Van Brussel
Neurobiology of Disease 35 ( 3) 474 -476

65
2009
A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease.

Stéphane Mievis , David Blum , Catherine Ledent
Neurobiology of Disease 41 ( 2) 570 -576

40
2011
Worsening of Huntington disease phenotype in CB1 receptor knockout mice

Stéphane Mievis , David Blum , Catherine Ledent
Neurobiology of Disease 42 ( 3) 524 -529

48
2011